danazol has been researched along with Hepatitis C, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, H; Luketic, VA; Price, AS; Purrington, A; Sanyal, AJ; Shiffman, ML; Sterling, RK; Stravitz, RT | 1 |
| Aslan, V; Aykin, N; Cevik, F; Demirdal, T; Demirturk, N | 1 |
2 other study(ies) available for danazol and Hepatitis C, Chronic
| Article | Year |
|---|---|
Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C.
Topics: Antibodies; Danazol; Drug Hypersensitivity; Epoetin Alfa; Erythropoietin; Estrogen Antagonists; Follow-Up Studies; Hematinics; Hepatitis C, Chronic; Humans; Male; Middle Aged; Radioimmunoprecipitation Assay; Recombinant Proteins; Red-Cell Aplasia, Pure | 2005 |
Autoimmune thrombocytopenia induced by PEG-IFN-alpha plus ribavirin in hepatitis C.
Topics: Adult; Antiviral Agents; Danazol; Drug Carriers; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Immunoglobulins, Intravenous; Interferon-alpha; Purpura, Thrombocytopenic, Idiopathic; Ribavirin | 2006 |